Stay updated on Microbiota Transfer Therapy in Adults with ASD Clinical Trial

Sign up to get notified when there's something new on the Microbiota Transfer Therapy in Adults with ASD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Microbiota Transfer Therapy in Adults with ASD Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in a clinical trial of Microbiota Transfer Therapy (MTT) for adults with autism spectrum disorders (ASD) who have gastrointestinal problems, aiming to evaluate the safety and efficacy of the treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:33:40.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying that adults aged 18-60 with a diagnosis of autism and a gastrointestinal disorder are eligible. Previously, this section had no information provided.
    Difference
    19%
    Check dated 2024-05-22T20:59:20.000Z thumbnail image
  8. Check
    42 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:35:32.000Z thumbnail image

Stay in the know with updates to Microbiota Transfer Therapy in Adults with ASD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Microbiota Transfer Therapy in Adults with ASD Clinical Trial page.